Terminal · Institutions
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Every 13F-reported equity position this quarter, with its quarter-over-quarter change — each row traces back to the SEC filing.
Artal Group S.A. (CIK 1053906) reported $1.01B across 2 reported positions in its SEC 13F filing for 2026-03-31. Largest positions: CAVA ($769.2M, 76.11%), LXRX ($241.4M, 23.89%). Source: SEC Form 13F.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | CAVA | Cava Group Inc | $769.2M | 76.11% | 9.5M | Hold |
| 2 | LXRX | Lexicon Pharmaceuticals Inc | $241.4M | 23.89% | 154.7M | Added |
Source: SEC Form 13F filings · as of 2026-03-31